Kip Bohnert, PhD

Associate Professor of Epidemiology and Biostatistics

Department of Epidemiology and Biostatistics
909 Wilson Road Room B601
East Lansing, Michigan 48824

Dr. Bohnert received his B.A. in Public Health from the Johns Hopkins University and his Ph.D. in Epidemiology from Michigan State University. Following the completion of a postdoctoral fellowship in Health Services Research at the University of Michigan and the VA Ann Arbor Healthcare System, he joined the faculty in the Department of Psychiatry at the University of Michigan and the VA Ann Arbor Center for Clinical Management Research. He held these appointments until his arrival as Associate Professor in the Department of Epidemiology and Biostatistics at Michigan State University. Dr. Bohnert’s research seeks to better understand the causes and consequences of substance use, substance use disorder, and other mental health conditions, as well as help identify and address gaps in care for individuals with such conditions. Specific domains of his research agenda include the study of: 1) individuals who use cannabis, with a particular emphasis on understanding the similarities and differences between those who use medically versus recreationally, and health outcomes associated with cannabis use; 2) the health service needs of individuals with substance use, PTSD, and other mental health problems; 3) variable- and person-centered approaches to longitudinally model symptom course, treatment initiation and engagement, and health outcomes for individuals who use alcohol, tobacco, and other drugs, as well as for individuals with other psychiatric illnesses.

Dr. Bohnert’s research activities are funded by the VA, the National Institutes of Health, and the Centers for Disease Control and Prevention. Dr. Bohnert was the recipient of a VA HSR&D Career Development Award examining mental health and substance use services delivery following behavioral health screening in the primary care setting. He is PI of a VA Merit Award examining patterns of cannabis use and health, functioning, and service utilization among primary care patients, as well as a recently funded NIAAA R01 testing a PTSD m-Health intervention to improve alcohol treatment outcomes.